Elomatic-Pharmalab Consulting And Engineering Private Limited - Company Profile

It is a engineering private limited company based in Thane West, Maharashtra, India, established in 2004.
2004 Thane West, Maharashtra, India Active
Last Updated:
Access Report
About Elomatic-Pharmalab Consulting And Engineering Private Limited

Elomatic-Pharmalab Consulting And Engineering Private Limited, a active private limited company, was established on 27 October 2004 in Thane West, Maharashtra, India. Engaging in procurement & construction (epc) within the professional, scientific and technical sector, it holds CIN: U73100MH2004PTC149278. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹5.17 Cr.

It upholds a compliant status. Its leadership includes Vishal Umesh Shah (Director), Umesh Purushottam Shah (Director), Mona Akerholm Daniela (Director). Past directors included Nitin Purushottam Shah, Vishal Umesh Shah, Ted Roger Bergman. It holds no open charges and ₹6.04 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at Centrum, Unit No. 301 To 304, Opp. Tmc Office Next To Satkar Grande Hotel, Waghle Indl, Estate,, Thane West, Maharashtra, 400604.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100MH2004PTC149278

  • Registration Number

    149278

  • Incorporation Date

    27 October 2004

  • Authorized Capital

    ₹7.50 Cr

  • Paid-Up Capital

    ₹5.17 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 Cr
  • Paid Up Capital ₹ 5.17 Cr
  • Company Age 21 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 6.04 M
  • Revenue Growth **** 19.67%
  • Profit Growth **** -19.63%
  • Ebitda **** 21.02%
  • Net Worth 20.35%
  • Total Assets **** 10.40%
Company report

Elomatic-Pharmalab Consulting And Engineering Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elomatic-Pharmalab Consulting And Engineering Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Elomatic-Pharmalab Consulting And Engineering Private Limited?
Current Directors
Name Designation Appointment Date Status
Vishal Umesh Shah Director 11 Aug 2020 Current
Umesh Purushottam Shah Director 27 Oct 2004 Current
Mona Akerholm Daniela Director 21 Apr 2022 Current
Tom Henrik Lind Director 30 Jul 2024 Current
Tero Seppo Juhani Tuomela Director 30 Sep 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 13 Aug 2020 Past
Pramod Abcsdd Additional Director 28 Dec 2020 Past
Pramod Abcsdd Additional Director 21 Apr 2022 Past
Pramod Abcsdd Additional Director 28 Dec 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2022 Past
Pramod Abcsdd Director 07 Aug 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elomatic-Pharmalab Consulting And Engineering.

Elomatic-Pharmalab Consulting And Engineering Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.67% increase. The company also saw a substantial fall in profitability, with a 19.63% decrease in profit. The company's net worth Soared by an impressive increase of 20.35%.

Elomatic-Pharmalab Consulting And Engineering revenue growth over time
Elomatic-Pharmalab Consulting And Engineering profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 19.67%
*******
*******
*******
*******
Revenue from Operations
*******
 23.18%
*******
*******
*******
*******
Total Assets
*******
 10.40%
*******
*******
*******
*******
Profit or Loss
*******
 -19.63%
*******
*******
*******
*******
Net Worth
*******
 20.35%
*******
*******
*******
*******
EBITDA
*******
 21.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elomatic-Pharmalab Consulting And Engineering?

In 2023, Elomatic-Pharmalab Consulting And Engineering had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹6,040,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.60 Cr
Latest Charge Details
Date Lender Amount Status
16 Jun 2021 Canara Bank ₹0.74 M Satisfied
05 Mar 2014 Canara Bank ₹2.50 M Satisfied
17 Feb 2014 Canara Bank ₹2.50 M Satisfied
01 Nov 2007 Canara Bank ₹0.30 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Elomatic-Pharmalab Consulting And Engineering?

Unlock and access historical data on people associated with Elomatic-Pharmalab Consulting And Engineering, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elomatic-Pharmalab Consulting And Engineering, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elomatic-Pharmalab Consulting And Engineering's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elomatic-Pharmalab Consulting And Engineering
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Elomatic-Pharmalab Consulting And Engineering Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Tom Henrik Lind was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.

  • Balance Sheet

    The activity Elomatic-Pharmalab Consulting And Engineering Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Charges

    The activity A charge registered on 05 Mar 2014 via Charge ID 10483442 with Canara Bank was fully satisfied on 16 Oct 2023. was completed.

  • Charges

    The activity A charge registered on 17 Feb 2014 via Charge ID 10481305 with Canara Bank was fully satisfied on 16 Oct 2023. was completed.

  • Charges

    A charge registered on 01 Nov 2007 via Charge ID 10074841 with Canara Bank was fully satisfied on 16 Oct 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elomatic-Pharmalab Consulting And Engineering Private Limited?

The CIN of Elomatic-Pharmalab Consulting And Engineering Private Limited is U73100MH2004PTC149278.

Where is Elomatic-Pharmalab Consulting And Engineering Private Limited headquartered?

Elomatic-Pharmalab Consulting And Engineering Private Limited is headquartered at Centrum, Unit No. 301 To 304, Opp. Tmc Office Next To Satkar Grande Hotel, Waghle Indl, Estate,, Thane West, Maharashtra, 400604.

When was Elomatic-Pharmalab Consulting And Engineering Private Limited incorporated?

Elomatic-Pharmalab Consulting And Engineering Private Limited was incorporated on 27 October 2004.

Who are the current directors of Elomatic-Pharmalab Consulting And Engineering Private Limited?

The current directors of Elomatic-Pharmalab Consulting And Engineering Private Limited are

What is the primary industry of Elomatic-Pharmalab Consulting And Engineering Private Limited?

The primary industry of Elomatic-Pharmalab Consulting And Engineering Private Limited is Professional, Scientific And Technical.

Is Elomatic-Pharmalab Consulting And Engineering Private Limited a listed company?

Elomatic-Pharmalab Consulting And Engineering Private Limited is unlisted.

What is the capital structure of Elomatic-Pharmalab Consulting And Engineering Private Limited?

The authorized capital of Elomatic-Pharmalab Consulting And Engineering Private Limited is ₹7.50 Cr, and the paid-up capital is ₹5.17 Cr.

What is the compliance status of Elomatic-Pharmalab Consulting And Engineering Private Limited?

The compliance status of Elomatic-Pharmalab Consulting And Engineering Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available